The Journal of Dental Panacea

Online ISSN: 2348-8727

CODEN : JDP

The Journal of Dental Panacea (JDP) open access, peer-reviewed quarterly journal, Publish quarterly as Open Access (OA).  Vision of this journal  for better dissemination of knowledge, Journal will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in JDP. Manuscripts must be prepared in accordance with “Uniform requirements” of the The Journal of Dental Panacea as more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 195

PDF Downloaded: 96


Get Permission Srivastava: Impact of osteoporosis on oral health


Introduction

Osteoporosis is a type of bone disease that occurs when the bone mass content and mineral density decline. This may result in a weakening of the bones, hovering the possibility of fractures.1 In 1994 World Health Organization (WHO) stated that osteoporosis is "a disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enlarged bone fragility and a consequent increase in fracture risk." 2 Osteoporosis is a systemic skeletal disorder with compromised bone density. Osteoporosis is a slowly progressive disease that causes low bone mass in the bones, weakening of the immune system that increases the risk of fractures, deterioration of the microarchitecture of the bones, and knee and back pain. Osteoporosis occurs when the bone resorption rate is higher than the bone formation rate, bone turnover increases, and bone loss occurs. In oral cavity this disease has definite adverse effects on both tooth health and stability and also residual alveolar crest.3 Throughout life, it affects both the sexes, but postmenopausal women are more likely to experience it. Apparently about 50% of postmenopausal women will experience problems related to osteoporosis. Bone resorption is a common feature of both periodontitis and osteoporosis.4, 5, 6 Following an infectious breach of the alveolar cortical bone, periodontitis causes localized inflammatory bone loss and may lead to tooth loss. The association between osteoporosis and periodontitis has been confirmed by cross-sectional studies based mainly on radiological measurements and, to a lesser extent, clinical tests. Common risk factors include age, genetics, hormonal fluctuations, smoking, and inadequate calcium and vitamin D. This relationship can be explained by mechanisms such as hormonal balance, pain resolution, and the effects of bone remodeling homeostasis.7, 8 Furthermore, there's a chance that the two conditions will interact and become risk factors for one another, requiring concurrent care. The linkage may be explained by mechanisms including hormone balance, inflammation resolution, and bone remodeling homeostasis disruption. With intricate treatment interactions, a mutual interventional approach is beginning to take shape.9

Classification

Osteoporosis can be classified based on etiology and severity of the disease. Osteoporosis is defined based on bone mineral density (BMD). For this a standardized score, called T-score is allocated, which compares BMD to average values. 10 The categories for diagnosis according to severity are:

  1. Normal (T-score -1.0 and above).

  2. Low bone density, referred to as osteopenia (T-score between -1.0 and -2.5).

  3. Osteoporosis (T-score -2.5 and below).

  4. Severe osteoporosis (T-score -2.5 and below with history of a fracture).

The etiology of osteoporosis can also be used to categorize it into primary and secondary forms. 3 The cause of majority of cases of primary osteoporosis is still unknown, whereas secondary osteoporosis develops in response to a specific disease with a known etiology. Osteogenesis Imperfecta, Idiopathic, Juvenile Osteoporosis, and so forth are other forms of osteoporosis. Primary osteoporosis can be divided into type I postmenopausal osteoporosis (aged 50 to 70 years) and type II senile osteoporosis (over 70 years of age, affecting trabecular and cortical bones).

Diagnosis

For a more accurate diagnosis, there must be some history of bone loss or low bone density formation. In the absence of bone, low bone mass can occur. Postnatal osteoporosis-BMD deficit in Caucasian adults was 2.5 standard deviations below the reference mean in youth. In osteopenia- Inadequate BMD, 1.25 standard deviations below the youth mean. 11

Bone Mineral Density

A decline in BMD with one standard deviation increases the risk of fracture by two times. Breaks caused by osteoporosis:

  1. 1:2 Female

  2. 1:3 Male

  3. >60 years old;

  4. Cascade effect of vertebral fractures

Risk Factors

In general, there are two types of osteoporosis risk factors: modifiable and non-modifiable. Preventing osteoporosis can lessen the chance of crippling fractures and slow the rate of bone loss. There are many ideas to consider on this topic. Modifiable factors include quitting smoking and living a sedentary lifestyle, maintaining a healthy, balanced diet, and having few intestinal or renal disorders, which can increase the risk of inadequate calcium and phosphorus absorption and vitamin D deficiency. 12 On the other hand, risk factors that cannot be changed include age, gender, menopause status, ethnicity, family history, low birth weight, anorexia nervosa, hyperthyroidism, and low testosterone levels.

Pathophysiology of Osteoporosis

According to the literature, there are two types of osteoporosis: primary and secondary. It is stated that primary osteoporosis is an ailment with no known cause. It is also referred to as senile osteoporosis and can develop with ageing, accelerating at menopause. 13 Conversely, secondary osteoporosis results from known causes, such as dietary habits, lifestyle choices, or a patient's underlying medical condition. The patient's medical history may be linked to osteoporosis; these conditions include parkinsonism, autoimmune disorders, hematological disorders such as multiple myeloma and leukemia, endocrine disorders, and genetic mutations resulting in hypogonadal state.

An imbalance between bone formation and resorption is the fundamental cause of osteoporosis, both primary and secondary types. This imbalance causes bones to grow inadequately or to become inadequate and lose strength during growth. Fragile bone tissue is undoubtedly the result of excessive bone resorption combined with inadequate new bone formation. Hormonal factors also play a pivotal role in adjudicating the rate of bone resorption. Osteoporosis is caused by a lack of estrogen in two ways: 1) by making more osteoclasts and reducing their apoptosis; 2) by inhibiting the production of pro-inflammatory cytokines such as interleukins 1 and 6, TNFα, and prostaglandin E2, which causes the production of more pre-osteoclasts in the bone marrow. 3, 14

Assessment of Oral Bone Loss

Oral indicators of osteoporosis include excessive alveolar ridge resorption, tooth loss, insistently disparaging periodontal disease, referred maxillary sinus pain and frequent fractures. In the mandibular region the cortical bone is more disposed to overall bone loss than the trabecular portion or the remaining height of the alveolar process. Associated to the lingual cortex, the buccal cortex which is situated distal to the mental foramen shows a greater correspondence with skeletal mineral density values. 3 Alveolar bone resorption is subjective by the severity of underlying periodontal disease and, if the patient wears a denture, the denture's quality. Dental diseases are frequently screened for with dental panoramic radiographs. The unintentional discoveries found on panoramic radiographs may be used to identify women who have no awareness of their low BMD. By looking for evidence of resorption on panoramic radiographs, a number of mandibular cortical indices have been developed to determine osteopenia and evaluate the quality of mandibular bone mass. Among these are the Panoramic Mandibular Index (PMI) and the Mandibular Cortical Index (MCI). 3, 15

Oral Considerations in Osteoporosis

In various studies it has been stated that osteopenia may be a risk factor for periodontal disease along with other systemic risk factors like smoking, diabetes and obesity. Many studies have experimentally concluded that interproximal bone loss is concomitant to BMD in postmenopausal women. Women with low BMD and high calculus apposition had a advanced clinical attachment loss than women with normal BMD and analogous calculus apposition. 3 Gingival inflammation in osteoporotic early menopausal women and attachment loss are the cause of early tooth loss. These factors are reduced by serum estroidal supplementation. It is also well known that the alveolar BMD and alveolar bone height may both decline in conjunction with the loss of posterior teeth. Enduring ridge resorption in patients with complete dentures is a biological phenomenon brought on by a diminution in biomechanical loading on bone, which let down the stresses on the periosteal surface and inside the bone itself, sooner or later consequential in resorption. A survey of the last fifteen years' literature reveals the relationship between BMC and residual ridge resorption. Osteoporosis ominously marks the reduction of residual ridge in edentulous patients, according to Hirai T et al. 16 Significant mandibular ridge height was also found to be associated with either localized or systemic bone loss in quite a few further researches.

Relationship between Periodontitis and Osteoporosis

Osteoporosis and periodontitis are common inflammatory skeletal disorders that present serious public health issues to our aging population. Clinical study accomplices and measurement procedures used in clinical studies determine the relationship between osteoporosis and periodontitis. 10 Osteoporosis affects more in women than in men, whereas periodontitis primarily affects men. Furthermost cross-sectional association studies among older post-menopausal women revealed a general positive relationship, suggesting that this type of connotation might exist in this specific subgroup of the population. 17 In addition, contingent on the clinical and radiographic parameters used for both diseases, the degree of association may vary pointedly. 18 These days, quantitative computer tomography (QCT), dual-photon absorptiometry (DPA), and dual-energy absorptiometry (DXA) are the approaches accustomed to evaluate osteoporosis.19 Osteoporosis is defined by the World Health Organization (WHO) as a bone mineral density (BMD) T-score 2.5 as standard deviations below the average peak in young adults. The hip, femur, and spine are the preferred sites for osteoporosis diagnosis using bone mineral density (BMD). Variability may also arise from different studies that use continuous BMD for statistical assessment versus dichotomous diagnosis approaches. Conversely, radiographic measures for alveolar crest height (ACH), tooth loss, absolute bone density (DXA, DPA, QCT), and computer-assisted densitometry image analysis (CADIA) are amongst the techniques used to assess periodontal conditions and oral bone loss. Periodontal disease parameters can be divided into two categories: radiographic considerations (ACH, DXA, DPA, QCT) and clinical examinations (PD, CAL, tooth loss). Although there is a strong correlation with tooth loss, the precise relationship between osteoporosis and the clinical characteristics of periodontitis is still unknown, as per a recent systematic review. But when determining radiographic findings (osteoporotic change of the jaw or alveolar bone), there is, nevertheless, a very strong association. These results point toward a unique molecular relationship between the two bone resorbing circumstances. 10, 20 Interdisciplinary approaches are necessary for the prevention and treatment of both conditions, as well as the need for additional carefully monitored longitudinal and interventional research to bolster evidence-based clinical recommendations. Both conditions require expensive, continuous dental and medical care.

Prevention of Osteoporosis

  1. Smoking should be stopped

  2. Calcium supplement

  3. Vitamin-D Supplement.

  4. Medication

  5. Weight bearing Exercise

  6. Check your risk factors

  7. Reduce Alcohol

Conclusion

Comprehending the molecular mechanisms that underpin their association illuminates prospective therapeutic approaches that could aid in the co-management of both systemic and skeletal loss. The pro-inflammatory tissue microenvironment in both diseases is driven by age-related oxidative stress and senescence, which in turn causes an uncoupling of the bone remodeling process. Smoking and a lack of vitamin D are two of their common risk factors, and these mechanistic connections are at work. Better patient care can be achieved when interdisciplinary management and possible therapies to treat both diseases are appropriately put into practice.

Source of Funding

None.

Conflict of Interest

None.

References

1 

NC Wright AC Looker KG Saag JR Curtis ES Delzell, S Randall The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineJ Bone Miner Res2014291125206

2 

JA Kanis Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study GroupOsteoporos Int19944636881

3 

V Bandela B Munagapati RK Karnati GR Venkata SR Nidudhur Osteoporosis: Its Prosthodontic Considerations - A ReviewJ Clin Diagn Res201591214

4 

PJ Kribbs Comparison of mandibular bone in normal and osteoporotic womenJ Prosthet Dent199063221822

5 

JB Payne RA Reinhardt PV Nummikoski KD Patil Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic womenOsteoporos Int19991013440

6 

J Wactawski-Wende SG Grossi, M Trevisan RJ Genco M Tezal R G Dunford The role of osteopenia in oral bone loss and periodontal diseaseJ Periodontol19966710107684

7 

M Tezal The relationship between bone mineral density and periodontitis in postmenopausal womenJ Periodontol200071914921500

8 

V S Narayanan L Ashok Osteoporosis: Dental ImplicationJ Indian Acad Oral Med Rad20112332115

9 

H Devlin PD Allen J Graham R Jacobs K Karayianni C Lindh Automated osteoporosis risk assessment by dentists: a new pathway to diagnosisBone200740483542

10 

S Silverman B Abrahamsen The Duration and Safety of Osteoporosis Treatment1stSpringer International Publishing Switzerland 2016

11 

CM Holahan S Koka, KA Kennel AL Weaver DA Assad FJ Regennitter Effect of osteoporotic status on the survival of titanium dental implantsInt J Oral Maxillofac Implants200823590510

12 

CM Weaver CM Gordon KF Janz HJ Kalkwarf JM Lappe R Lewis The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendationsOsteoporos Int20162741281386

13 

N Kapoor KE Cherian BK Pramanik S Govind ME Winford S Shetty Association between Dental Health and Osteoporosis: A Study in South Indian Postmenopausal WomenJ Midlife Health20178415962

14 

P Augat T Fuerst H K Genant Quantitative bone mineral assessment at the forearm: a reviewOsteoporos Int199884299310

15 

A Yoshihara Y Seida N Hanada H Miyazaki A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older adultsJ Clin Periodontol20043186804

16 

T Hirai T Ishijima Y Hashikawa T Yajima Osteoporosis and reduction of residual ridge in edentulous patientsJ Prosthet Dent19936914956

17 

MA Martinez-Maestre C González-Cejudo G Machuca R Torrejón C Castelo-Branco Periodontitis and osteoporosis: A systematic reviewClimacteric20101365239

18 

L Levin I Shpigel B Peretz The use of a self-report questionnaire for dental health status assessment: A preliminary studyBr Dent J201321451510.1038/sj.bdj.2013.224

19 

S Anil RS Preethanath HS AlMoharib KP Kamath PS Anand Impact of osteoporosis and its treatment on oral healthAm J Med Sci20133465396401

20 

H Sobczak-Jaskow B Kochanska B Drogoszewska Composition and Properties of Saliva in Patients with Osteoporosis Taking Antiresorptive DrugsInt J Environ Res Public Health20232054294



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.

Article type

Review Article


Article page

122-125


Authors Details

Ruchi Srivastava*


Article History

Received : 15-03-2024

Accepted : 27-04-2024


Article Metrics


View Article As

 


Downlaod Files